Why Is Boxed Stock Down 41 percent Today?
| JNCEDelisted Stock | USD 1.88 0.00 0.00% |
About 56% of Jounce Therapeutics' investor base is looking to short. The analysis of current outlook of investing in Jounce Therapeutics suggests that many traders are alarmed regarding Jounce Therapeutics' prospects. The current market sentiment, together with Jounce Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Jounce Therapeutics stock news signals to limit their universe of possible portfolio assets.
Jounce |
Boxed stock is falling hard on Wednesday after the company floated the possibility of a bankruptcy filing to investors.
Read at investorplace.com
 |
Jounce Therapeutics Fundamental Analysis
We analyze Jounce Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jounce Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jounce Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
Jounce Therapeutics is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Jounce Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Jounce Therapeutics stock to make a market-neutral strategy. Peer analysis of Jounce Therapeutics could also be used in its relative valuation, which is a method of valuing Jounce Therapeutics by comparing valuation metrics with similar companies.
Peers
Jounce Therapeutics Related Equities
| CTMX | CytomX Therapeutics | 7.87 | ||||
| NUVB | Nuvation Bio | 3.21 | ||||
| ACHL | Achilles Therapeutics | 0.94 | ||||
| NXTC | NextCure | 0.84 | ||||
| TIL | Instil Bio | 0.08 | ||||
| SPRO | Spero Therapeutics | 0.86 | ||||
| ASMB | Assembly Biosciences | 1.53 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Jounce Stock
If you are still planning to invest in Jounce Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Jounce Therapeutics' history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |